Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
April 23, 2024
April 10, 2024
April 05, 2024
March 27, 2024
January 29, 2024
January 22, 2024
January 19, 2024